Rodrigues Dominic 13D and 13G filings for Provectus Biopharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-12-08 09:53 am Purchase | 2025-12-02 | 13D | PROVECTUS BIOPHARMACEUTICALS, PVCT | Rodrigues Dominic | 25,220,549 5.670% | 25,220,549 (New Position) | Filing |